Camp4 Therapeutics (CAMP) Other Non-Current Liabilities (2023 - 2026)

Camp4 Therapeutics has reported Other Non-Current Liabilities for 4 years, with the latest figure at $30000.0 in Q1 2026.

• Quarterly Other Non-Current Liabilities rose 1400.0% year-over-year to $30000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $30000.0 (up 1400.0% YoY) and the FY2025 annual result came in at $29000.0, down 59.72% from the prior year.
• Other Non-Current Liabilities grew to $30000.0 in Q1 2026 per CAMP's latest filing, from $29000.0 in the prior quarter.
• Over five years, Other Non-Current Liabilities peaked at $16.7 million in Q3 2025 and troughed at $2000.0 in Q4 2023.
• A 4-year average of $2.1 million and a median of $15500.0 in 2023 frame the typical range for Other Non-Current Liabilities.
• The widest YoY moves for Other Non-Current Liabilities: up 836500.0% in 2025, down 59.72% in 2025.
• Over 4 years, Other Non-Current Liabilities stood at $2000.0 in 2023, then soared by 3500.0% to $72000.0 in 2024, then slumped by 59.72% to $29000.0 in 2025, then grew by 3.45% to $30000.0 in 2026.
• According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $30000.0, $29000.0, and $16.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.